Abstract
(Q)SAR ((quantitative or qualitative) structure-activity relationships) methodologies are used to predict physical and biological properties of small molecules. These methods are used to support pharmaceutical research and regulatory submissions. Primarily, (Q)SARs are used to predict the activity of untested chemicals based on structurally related compounds with known activity. The term (Q)SAR is often used to refer to predictive models, especially computer-based models; however, in reality (Q)SAR encompasses a wide variety of computerized (i.e., in silico) and non-computerized tools and approaches. As a tool, (Q)SAR is accepted internationally for predicting mutagenicity; however, its applicability for predicting additional endpoints (e.g., skin sensitization or hepatotoxicity) is still an active debate topic, particularly debates about the acceptability of the (Q)SAR models for additional endpoints and how they are either explained or interpreted. After discussing the basics of (Q)SAR, we relate (Q)SAR methodologies to inexpensive and practical applications.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alves, V., Muratov, E., Capuzzi, S., Politi, R., Low, Y., Braga, R., Zakharov, A. V., Sedykh, A., Mokshyna, E., Farag, S., Andrade, C., Kuz'min, V., Fourches, D., & Tropsha, A. (2016). Alarms about structural alerts. Green Chemistry, 18(16), 4348–4360.
Ashby, J. (1985). Fundamental structural alerts to potential carcinogenicity or noncarcinogenicity. Environmental Mutagenesis, 7(6), 919–921.
Benfenati, E., Pardoe, S., Martin, T., Gonella Diaza, R., Lombardo, A., Manganaro, A., & Gissi, A. (2013). Using toxicological evidence from QSAR models in practice. ALTEX, 30(1), 19–40. https://doi.org/10.14573/altex.2013.1.019.
Benigni, R., & Bossa, C. (2006). Structural alerts of mutagens and carcinogens. Current Computer-Aided Drug Design, 2, 1–19. 169–176.
Benigni, R., Bossa, C., Jeliazkova, N., Netzeva, T., Worth, A. (2008). The Benigni/Bossa rulebase for mutagenicity and carcinogenicity-a module of Toxtree 2(008) Available at https://eurl-ecvam.jrc.ec.europa.eu/laboratories-research/predictive_toxicology/doc/EUR_23241_EN.pdf
Braga, R. C., & Andrade, C. H. (2012). (2012) QSAR and QM/MM approaches applied to drug metabolism prediction. Mini Reviews in Medicinal Chemistry, 12(6), 573–582.
Caldwell, G. W. (2000). Compound optimization in early- and late-phase drug discovery: Acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens. Current Opinion in Drug Discovery & Development, 3(1), 30–41.
Cariello, N. F., Wilson, J. D., Britt, B. H., Wedd, D. J., Burlinson, B., & Gombar, V. (2002). Comparison of the computer programs DEREK and TOPKAT to predict bacterial mutagenicity. Deductive estimate of risk from existing knowledge. Toxicity prediction by Komputer assisted technology. Mutagenesis, 17(4), 321–329.
Cherkasov, et al. (2014). QSAR modeling: Where have you been? Where are you going to? Journal of Medicinal Chemistry, 57(12), 4977–5010.
Cramer, G. M., Ford, R. A., & Hall, R. A. (1978). Estimation of toxic hazard—a decision tree approach. Food and Chemical Toxicology, 16, 255–276.
Crum-Brown, & Fraser. (1868). On the connection between chemical constitution and physiological action; with special reference to the physiological action of the salts of the ammonium bases derived from strychnia, brucia, thebaia, codeia, morphia, and nicotia. Journal of Anatomy and Physiology, 2(2), 224–242.
Curios‐IT. (2009). Cramer rules with extensions. Leiden: Curios‐IT.
EPA. (2012). (Quantitative) Structure Activity Relationship [(Q)SAR] guidance document. Retrteived online 2019 from https://archive.epa.gov/pesticides/news/web/pdf/qsar-guidance.pdf
ICH M7. (2017). Assessment and control of DNA reactive (mutagenic) impurities in pharmaceuticals to limit potential carcinogenic risk.
Jawarkar, S. G., & Game, M. D. (2018). Quantitative structure activity relationship: A tool for new drug design. World Journal of Pharmaceutical Sciences. ISSN (Online): 2321–3086.
Jhanwarb, et al. (2011). QSAR - Hansch analysis and related approaches in drug design. Pharmacology, 1, 306–344.
JRC. (2016). JRC Technical reports; NANoREG harmonised terminology for environmental health and safety assessment of nanomaterials. Retrieved online from https://ec.europa.eu/jrc/en/publication/nanoreg-harmonised-terminology-environmental-health-and-safety-assessment-nanomaterials
Kroes, R., Renwick, A. G., Cheeseman, M., Kleiner, J., Mangelsdorf, I., Piersma, A., et al. (2004). Structure-based thresholds of toxicological concern (TTC): Guidance for application to substances present at low levels in the diet. Food and Chemical Toxicology, 42(1), 65–83.
Lapenna S & Worth A (2011), Analysis of the Cramer classification scheme for oral systemic toxicity - implications for its implementation in Toxtree. EUR 24898 EN. Publications Office of the European Union, Luxembourg.
Lhasa (2019) ICH M7 Assessment using Derek Nexus. Retrieved online from https://www.lhasalimited.org/products/ICH-M7-assessment-using-derek-nexus.htm
LSMA. (2016). Leadscope model applier and the ICH M7 impurities guidelines frequently asked questions. Retrieved online from https://www.leadscope.com/faq/LSMA-ICHM7-FAQs-June2016.pdf.
Munro, I. C., Ford, R. A., Kennepohl, E., & Sprenger, J. G. (1996). Correlation of structural class with no-observed-effect levels: A proposal for establishing a threshold of concern. Food and Chemical Toxicology, 34(9), 829–867.
NAFTA. (2011). Technical Working Group on Pesticides (TWG). (Quantitative) Structure Activity Relationship [(Q)SAR] guidance document. Retrieved online from http://www.oecd.org/chemicalsafety/testing/49963576.pdf.
OECD. (2007). Guidance document on the validation of (Quantitative)Structure-Activity Relationships [(Q)Sar] models. Retrieved online 2019 from http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono%282007%292&doclanguage=en
Piir, G., Kahn, I., García-Sosa, A. T., Sild, S., Ahte, P., & Maran, U. (2018). Best practices for QSAR model reporting: Physical and chemical properties, ecotoxicity, environmental fate, human health, and toxicokinetics endpoints. Environmental Health Perspectives, 126(12), 126001.
Plošnik, A., Vračko, M., & Dolenc, M. S. (2016). Mutagenic and carcinogenic structural alerts and their mechanisms of action. Arhiv za Higijenu Rada i Toksikologiju, 67(3), 169–182.
Sanderson, D. M., & Earnshaw, C. G. (1991). Computer prediction of possible toxic action from chemical structure. Human & Experimental Toxicology, 10, 261–273.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bettis, J.L. (2019). An Introduction to (Q)SAR with Respect to Regulatory Submissions. In: Integrated Safety and Risk Assessment for Medical Devices and Combination Products. Springer, Cham. https://doi.org/10.1007/978-3-030-35241-7_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-35241-7_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-35240-0
Online ISBN: 978-3-030-35241-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)